| Business Summary | | OrthoLogic
Corporation
develops,
manufactures
and
markets
proprietary,
technologically
advanced
orthopedic
products
and
packaged
services
for
the
orthopedic
healthcare
market,
including
bone
growth
stimulation
devices
and
continuous
passive
motion
devices.
OrthoLogic's
products
are
designed
to
enhance
the
healing
of
diseased,
damaged,
degenerated
or
recently
repaired
musculoskeletal
tissue.
One
of
the
Company's
products,
the
OL1000,
is
a
portable,
non-invasive,
physician-prescribed
electromagnetic
field
bone
growth
stimulator
designed
for
patients
with
a
nonunion
fracture
of
certain
long
bones.
Another
product,
Spinalogic,
is
a
portable,
non-invasive,
electromagnetic
field
bone
growth
stimulator
that
enhances
the
healing
process
as
an
adjunct
to
spinal
fusion
surgery. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | OrthoLogic
Corporation
develops,
manufactures
and
markets
technologically
advanced
orthopedic
products
and
packaged
services
for
the
health
care
market.
For
the
six
months
ended
6/30/01,
revenues
fell
3%
to
$43.8
million.
Net
loss
totaled
$14.8
million
vs.
an
income
of
$1.2
million.
Revenues
reflect
the
termination
of
licensing
agreement
with
Sanofi-Synthelabo,
Inc.
Net
loss
reflects
a
one-time
cost
of
$14.3
million
related
to
the
sale
of
Continuous
Passive
Motion. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| John Holliman, III, 47 Chairman | -- | Thomas Trotter, 53 Pres,
CEO, Director | $423K | Terry Meier, 62 CFO,
Sr. VP | 237K | Shane Kelly, 31 VP
of Sales | -- | Donna Lucchesi, 37 VP
of Marketing | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|